ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU steps closer to generics and biosimilars manufacturing waiver pharmaphorum
February 28, 2019A change to European rules on drug manufacturing that could benefit makers of generics and biosimilars is edging closer, after lawmakers agreed draft legislation that tweaks rules on export and manufacture of drugs that are off-patent outside the EU.
Pharma Sources Insight January 2025
